Search International and National Patent Collections

1. (WO2018199627) PERSONALIZED ANTICANCER TREATMENT METHOD AND SYSTEM USING CANCER GENOME SEQUENCE MUTATION, TRANSCRIPT EXPRESSION, AND PATIENT SURVIVAL INFORMATION

Pub. No.:    WO/2018/199627    International Application No.:    PCT/KR2018/004799
Publication Date: Fri Nov 02 00:59:59 CET 2018 International Filing Date: Thu Apr 26 01:59:59 CEST 2018
IPC: G06F 19/18
G06F 19/24
G06F 19/28
G06F 19/00
Applicants: CIPHEROME
주식회사 싸이퍼롬
Inventors: KIM, Hye Hyeon
김혜현
LEE, Jeong Hoon
이정훈
Title: PERSONALIZED ANTICANCER TREATMENT METHOD AND SYSTEM USING CANCER GENOME SEQUENCE MUTATION, TRANSCRIPT EXPRESSION, AND PATIENT SURVIVAL INFORMATION
Abstract:
The present invention relates to a personalized anticancer treatment method and system using cancer genome sequence mutation, transcript expression, and patient survival information and, more particularly, to a method and system for selecting a personalized anticancer therapeutic drug, using synthetic dosage cancer survival gene pairs selected through patient's cancer genome sequence mutation information and transcript expression analysis. The personalized anticancer treatment method and system using cancer genome sequence mutation, transcript expression, and patient survival information according to the present invention is a technology that enables the selection of personalized anticancer therapeutic drugs having advantageous therapeutic effects and prognosis through the analysis of synthetic dosage cancer survival gene pairs and can promptly and simply provide relevant information of high reliability.